Scale -


  • Revenue is 106 Rs Cr; Continuous Decline over 3 years
  • Ebitda is 11.12 Rs Cr; Continuous Decline over 3 years
  • PAT is 4.09 Rs Cr; Continuous Decline over 3 years

Profitability -


  • Quarterly Profit margin is 4 %; Continuous Growth over 3 Quarters
  • PBDIT Margin is 10.5 %; 5 Year CAGR is 10 %

Return -


  • ROCE is 7.53 %; Annual Decline is -49 %; Continuous Decline over 3 years; 5 Year CAGR is -24 %
  • ROA is 2.04 %; Annual Decline is -33 %; Continuous Decline over 3 years; 5 Year CAGR is -21 %
  • ROE is 5.39 %; Annual Decline is -47 %; Continuous Decline over 3 years; 5 Year CAGR is -26 %
  • Asset Turnover is 62 %; Annual Decline is -24 %; Continuous Decline over 3 years; 5 Year CAGR is -22 %

Efficiency -


  • Inventory Turnover Ratio is 2.86; Annual Decline is -39 %; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -28 %
  • Operating cash flow is 0.73 Rs Cr; Annual Decline is -93 %; Continuous Decline over 3 years; 5 Year CAGR is -50 %
  • Quick Ratio is 0.77; in Bottom Quartile

Solvancy -


  • Debt/Equity is 1.01; Continuous Decline over 3 years; in Top Quartile
  • Long term Debt is 36.97 Rs Cr; Annual Growth is 55 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 33 %
  • Total Debt is 76.36 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 39 %

Quality -


  • Change in Inventories/Total Expenses is -11 %; Annual Decline is -239 %; Continuous Decline over 3 years; in Bottom Quartile
  • Operating cashflow/ebitda is 7 %; Annual Decline is -92 %; Continuous Decline over 3 years; 5 Year CAGR is -49 %
  • Operating cashflow/PAT is 18 %; Annual Decline is -93 %; Continuous Decline over 3 years; 5 Year CAGR is -46 %
  • Exceptional Items/PBT is 7 %; Continuous Growth over 3 years; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Godavari Drugs board approves ?340 million working capital limit from ICICI Bank
Godavari Drugs Ltd. Share Price Rise Streak: What Data Shows
Godavari Drugs Share Price live snapshot near 52-week peak